Related Experiment Video
Updated: Jun 12, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Clinical practice. Protein-losing enteropathy in children
Marjet J A M Braamskamp1, Koert M Dolman, Merit M Tabbers
1Department of Pediatrics, Sint Lucas Andreas Hospital, Amsterdam, The Netherlands.
European Journal of Pediatrics
|June 24, 2010
Summary
Protein-losing enteropathy (PLE) is a rare gastrointestinal disorder causing excessive protein loss. Diagnosis involves excluding other conditions and confirming with fecal alpha-1-antitrypsin levels.
Area of Science:
- Gastroenterology
- Internal Medicine
- Pathophysiology
Background:
- Protein-losing enteropathy (PLE) is a rare condition characterized by excessive protein loss into the gastrointestinal tract.
- It stems from impaired intestinal mucosal integrity and presents variably, often with edema due to hypoproteinemia.
Purpose of the Study:
- To outline the diagnostic criteria and management strategies for protein-losing enteropathy.
- To differentiate causes of PLE based on protein loss mechanisms (lymphatic vs. mucosal).
Main Methods:
- Diagnosis involves excluding other hypoproteinemia causes and confirming with elevated fecal alpha-1-antitrypsin.
- Identifying the underlying etiology through stool cultures, serologic tests, cardiac screening, and imaging.
Main Results:
- PLE can result from intestinal lymphangiectasia, congenital heart disease, or inflamed mucosal surfaces.
- Treatment focuses on nutritional support (high protein diet, vitamin supplements) and managing the underlying cause.
Conclusions:
- Effective management of PLE requires addressing the primary cause and providing nutritional support.
- Prognosis is contingent on the severity of the underlying disease and treatment efficacy.
Related Concept Videos
01:21Overview of Protein Metabolism
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...